Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Jul;16(1):22-9.
doi: 10.1128/jcm.16.1.22-29.1982.

Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates

Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates

R Ikeda et al. J Clin Microbiol. 1982 Jul.

Abstract

Antigenic analysis of the four serotypes of Cryptococcus neoformans was carried out by slide agglutination with reciprocal adsorption methods. With this procedure the antigenic patterns of the serotypes were established. Serotypes A and D had antigenic factors 1, 2, 3, 7 and 1, 2, 3, 8, respectively. Serotypes B and C were found to have antigenic factors 1, 2, 4, 5 and 1, 4, 6, respectively. Factor sera, prepared according to the antigenic patterns demonstrated by adsorption studies, proved to be useful for rapidly and accurately identifying C. neoformans serotypes. Some patterns similar to those of the C. neoformans serotypes were observed in five other Cryptococcus species and two Candida species. The proton magnetic resonance spectra of polysaccharides from the C. neoformans serotypes correlated well with their antigenic characteristics. Phenol oxidase test reactions and growth at 37 degrees C were useful criteria for determining which yeasts should be chosen for clinical application of factor sera for serotyping of C. neoformans. Sixty-two Japanese isolates of C. neoformans were serotyped. Fifty-eight of these isolates were serotype A, three were serotype A-D, and one was serotype D.

PubMed Disclaimer

References

    1. Proc Soc Exp Biol Med. 1968 Mar;127(3):820-3 - PubMed
    1. Nihon Saikingaku Zasshi. 1972 Jan;27(1):27-34 - PubMed
    1. Infect Immun. 1972 Jan;5(1):35-41 - PubMed
    1. J Clin Microbiol. 1975 Oct;2(4):354-8 - PubMed
    1. Mycologia. 1975 Nov-Dec;67(6):1197-200 - PubMed

LinkOut - more resources